Blog
RSS FeedPosted by Michael Wonder on 08 Sep 2022
Pharmac issues RFP for intravenous trastuzumab, a medicine used to treat breast cancer
8 September 2022 - PHARMAC is seeking commercial bids from pharmaceutical suppliers for the supply of intravenous trastuzumab, a ‘biologic’ ...
Posted by Michael Wonder on 07 Sep 2022
Blood cancer patients implore PHARMAC to fund desperately needed medicine
7 September 2022 - New Zealanders living with multiple myeloma are mounting a major, evidence-based campaign to press PHARMAC into funding ...
Posted by Michael Wonder on 05 Sep 2022
PHARMAC promises equity boost in first official response to independent review
6 September 2022 - PHARMAC will supercharge its commitment to Māori and diverse communities, which could see different medicines funded, ...
Posted by Michael Wonder on 02 Sep 2022
Call for Keytruda: Bay of Plenty couple needs help funding hefty cancer treatment
1 September 2022 - Tim Pardy thought he'd beat it. Five months later his pancreatic cancer not only returned, but it ...
Posted by Michael Wonder on 31 Aug 2022
New Zealand Pharmaceutical Schedule - 1 September 2022 update
1 September 2022 - The September 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Aug 2022
Government secures monkeypox medicine, PHARMAC working on getting vaccines
26 August 2022 - The Government has secured monkeypox medicine which is expected to be available in New Zealand from ...
Posted by Michael Wonder on 24 Aug 2022
Access criteria for new COVID-19 treatment announced
25 August 2022 - PHARMAC has today confirmed the access criteria for the first preventative medicine for COVID-19, tixagevimab and cilgavimab ...
Posted by Michael Wonder on 18 Aug 2022
PHARMAC makes cancer treatment available to more people
18 August 2022 - PHARMAC has confirmed today they are widening access from 1 September 2022 to a targeted cancer treatment, ...
Posted by Michael Wonder on 17 Aug 2022
PHARMAC estimates Trikafta could give people with CF another 27 years
17 August 2022 - PHARMAC has today published the record of advice from the May PTAC meeting to again consider ...
Posted by Michael Wonder on 15 Aug 2022
Calls for decision on Trikafta as new advice shows health system savings and decades more life for patients
15 August 2022 - Pressure is mounting on the Government to make a decision on whether it will fund the ...
Posted by Michael Wonder on 15 Aug 2022
PHARMAC shares update on its assessment of Trikafta
15 August 2022 - PHARMAC has today published the latest record of advice from PTAC and, for the first time, has ...
Posted by Michael Wonder on 09 Aug 2022
Has the innovative pharmaceutical industry essential given up trying to list new medicines in New Zealand?
10 August 2022 - Upon examining the agenda for this month's PTAC meeting, one would think that it has. ...
Posted by Michael Wonder on 06 Aug 2022
New Zealand allowed pharmacists to dispense COVID-19 antivirals and 'everyone realised it was a win'
6 August 2022 - With Australians dying from COVID-19 every day and nearly 5,000 people in hospital with the disease, experts ...
Posted by Michael Wonder on 03 Aug 2022
PHARMAC tells MPs medicine buying agency undergoing 'substantial change'
3 August 2022 - PHARMAC has undergone “substantial change” in the past few years, even before a hard hitting review ...
Posted by Michael Wonder on 02 Aug 2022
PHARMAC scrutiny a win for transparency
2 August 2022 - “PHARMAC’s appearance before the Health Select Committee tomorrow morning is a triumph for transparency and the ...